Editors' Note: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Lewis A, Galetta S. Neurology 2023;100:687.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lewis A, Galetta S. Editors' Note: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Neurology 2023;100:687.
PMID: 37012061